Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.39
Delayed Data
As of Jun 30
 -0.23 / -4.09%
Today’s Change
5.02
Today|||52-Week Range
12.59
-31.77%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Dineen John M
Director
Buy8/12/2015100,000$10.15$1.0M-48.67%
Nielsen Ulrik B
Director
Sale7/20/201520,000$10.71$214.2K-47.41%
Porter Michael E
Director
Buy8/12/201520,000$10.16$203.2K-48.67%
Lee Vivian S
Director
Buy2/29/201635,000$5.50$192.5K-6.91%
Sullivan William A
Chief Financial Officer & Treasurer
Sale7/15/201515,000$11.85$177.8K-53.25%
Porter Michael E
Director
Buy8/13/201510,000$10.65$106.5K-48.52%
Lee Vivian S
Director
Buy8/12/201510,000$10.05$100.5K-48.67%
Stewart Edward J
Sale7/15/20156,000$11.84$71.0K-53.25%
Porter Michael E
Director
Buy3/08/201610,000$7.09$70.9K-23.55%
Porter Michael E
Director
Buy3/01/201610,000$6.60$66.0K-17.33%
Page of 4